These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18446925)

  • 1. Drug subsidy could help Tanzania tackle malaria.
    Samarasekera U
    Lancet; 2008 Apr; 371(9622):1403-6. PubMed ID: 18446925
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug dispensing practices during implementation of artemisinin-based combination therapy at health facilities in rural Tanzania, 2002-2005.
    Thwing JI; Njau JD; Goodman C; Munkondya J; Kahigwa E; Bloland PB; Mkikima S; Mills A; Abdulla S; Kachur SP
    Trop Med Int Health; 2011 Mar; 16(3):272-9. PubMed ID: 21226795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination drug policy for malaria.
    Hook C
    Trop Doct; 2005 Jan; 35(1):59-60. PubMed ID: 15712565
    [No Abstract]   [Full Text] [Related]  

  • 4. Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
    Simba D; Kakoko D
    Tanzan J Health Res; 2012 Apr; 14(2):89-95. PubMed ID: 26591729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies.
    Briggs MA; Kalolella A; Bruxvoort K; Wiegand R; Lopez G; Festo C; Lyaruu P; Kenani M; Abdulla S; Goodman C; Kachur SP
    PLoS One; 2014; 9(4):e94074. PubMed ID: 24732258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malaria: a medical and economic problem].
    Bourée P
    Presse Med; 2006 Apr; 35(4 Pt 1):555-7. PubMed ID: 16614591
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
    Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
    Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affordable medicines facility for malaria.
    Bate R; Hess K
    Lancet Infect Dis; 2009 Jul; 9(7):396-7. PubMed ID: 19555897
    [No Abstract]   [Full Text] [Related]  

  • 9. Bridging the quality gap in diagnosis and treatment of malaria.
    Ikeda DJ; Gosling R; Eliades MJ; Chung A; Murungu J; Agins BD
    BMJ; 2020 Apr; 369():m1176. PubMed ID: 32321709
    [No Abstract]   [Full Text] [Related]  

  • 10. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
    Mori AT; Norheim OF; Robberstad B
    Pharmacoeconomics; 2016 Mar; 34(3):303-14. PubMed ID: 26521172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Global Fund and effective malaria treatment.
    Lidén J; Nantulya VM
    Lancet; 2004 Apr; 363(9418):1396. PubMed ID: 15110502
    [No Abstract]   [Full Text] [Related]  

  • 12. Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?
    Laxminarayan R; Over M; Smith DL
    Health Aff (Millwood); 2006; 25(2):325-36. PubMed ID: 16522574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global fund switches to artemisinin.
    Shetty P
    Lancet Infect Dis; 2004 Aug; 4(8):477. PubMed ID: 15298018
    [No Abstract]   [Full Text] [Related]  

  • 14. Artesunate for severe malaria.
    Lancet; 2011 Apr; 377(9776):1466. PubMed ID: 21531257
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO, the Global Fund, and medical malpractice in malaria treatment.
    Attaran A; Barnes KI; Curtis C; d'Alessandro U; Fanello CI; Galinski MR; Kokwaro G; Looareesuwan S; Makanga M; Mutabingwa TK; Talisuna A; Trape JF; Watkins WM
    Lancet; 2004 Jan; 363(9404):237-40. PubMed ID: 14738799
    [No Abstract]   [Full Text] [Related]  

  • 16. New funding mechanism is launched to combat malaria.
    Moszynski P
    BMJ; 2009 Apr; 338():b1627. PubMed ID: 19380401
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
    Wiseman V; Kim M; Mutabingwa TK; Whitty CJ
    PLoS Med; 2006 Oct; 3(10):e373. PubMed ID: 17032059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethiopia faces severe malaria epidemic. WHO predicts 15 million people could be infected.
    Das P
    Lancet; 2003 Dec; 362(9401):2071. PubMed ID: 14700064
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in willingness to pay for artemisinin-based combinations or monotherapy: experiences from the United Republic of Tanzania.
    Wiseman V; Onwujekwe O; Matovu F; Mutabingwa TK; Whitty CJ
    Bull World Health Organ; 2005 Nov; 83(11):845-52. PubMed ID: 16302041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-referral rectal artesunate in severe malaria.
    von Seidlein L; Deen JL
    Lancet; 2009 Feb; 373(9663):522-3. PubMed ID: 19059638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.